Log in

NASDAQ:MRSNMersana Therapeutics Earnings Date, Estimates & History

-0.98 (-4.54 %)
(As of 07/13/2020 04:00 PM ET)
Today's Range
Now: $20.59
50-Day Range
MA: $20.74
52-Week Range
Now: $20.59
Volume693,500 shs
Average Volume1.39 million shs
Market Capitalization$1.38 billion
P/E RatioN/A
Dividend YieldN/A


Mersana Therapeutics (NASDAQ:MRSN) Earnings Information

Mersana Therapeutics last released its earnings data on May 8th, 2020. The reported ($0.35) EPS for the quarter, beating analysts' consensus estimates of ($0.38) by $0.03. The firm earned $0.01 million during the quarter, compared to analyst estimates of $0.37 million. Mersana Therapeutics has generated ($0.65) earnings per share over the last year. Mersana Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 13th, 2020 based off prior year's report dates.

Mersana Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Mersana Therapeutics (NASDAQ:MRSN) Earnings Estimates

2020 EPS Consensus Estimate: ($1.30)
2021 EPS Consensus Estimate: ($1.47)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($0.37)($0.37)($0.37)
Q2 20202($0.39)($0.24)($0.32)
Q3 20202($0.35)($0.25)($0.30)
Q4 20202($0.36)($0.26)($0.31)
Q1 20211($0.37)($0.37)($0.37)
Q2 20211($0.39)($0.39)($0.39)
Q3 20211($0.35)($0.35)($0.35)
Q4 20211($0.36)($0.36)($0.36)

Mersana Therapeutics (NASDAQ MRSN) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/8/20203/31/2020($0.38)($0.35)($0.35)$0.37 million$0.01 millionTranscript
2/28/202012/31/2019($0.38)($0.34)($0.34)$0.50 million$0.04 millionTranscript
11/6/2019Q3($0.37)($0.35)($0.35)$0.50 million$0.84 millionListen
8/8/2019Q2 2019($0.38)($0.36)($0.36)$1.08 million$0.20 millionN/A
5/9/20193/31/2019($0.03)$0.70$0.70$30.11 million$41.04 millionN/A
3/8/201912/31/2018($0.69)($0.97)($0.97)$3.87 million$1.19 millionTranscript
11/13/2018Q3 2018($0.59)($0.75)($0.75)$3.98 million$2.15 millionN/A
8/15/2018Q2 2018($0.58)($0.54)($0.54)$3.74 million$4.19 millionN/A
5/14/2018Q1 2018($0.6130)($0.54)($0.54)$3.49 million$3.06 millionTranscript
3/28/2018Q4 2017($0.4830)($0.61)($0.61)$4.22 million$3.26 millionTranscript
11/9/2017Q3 2017($0.4850)($0.35)($0.35)$3.93 million$6.27 millionN/A
8/11/2017Q2 2017($0.5570)($6.33)($6.33)$3.33 million$3.73 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.